Corticotrophic and melanotrophic functions in congenital adrenal hyperplasia.
In 15 patients with congenital adrenal hyperplasia, the corticotrophic and melanotrophic functions were evaluated by plasma ACTH and beta-MSH radioimmunoassay. Evaluation of the corticotrophic and melanotrophic functions was also performed in 3 subjects after provocative tests (insulin-induced hypoglycaemia, metyrapone) and in 5 subjects after infusion of synthetic MIF (MSH-release inhibiting factor). The results indicate a significant increase in plasma ACTH and beta-MSH in CAH. In addition, we found that although in most cases there was a significant positive correlation between the plasma ACTH and beta-MSH levels, in some only the plasma ACTH values were high and beta-MSH values normal. No other anomalies of the corticotrophic and melanotrophic functions occurred in CAH as shown by the results of the provcative tests. Lastly, it must be emphasized that no modifications of plasma beta-MSH after synthetic MIF infusion were found in subject with normal or high plasma beta-MSH. These findings induce us to consider it unlikely that synthetic MIF is active in man.
D000293:Adolescent; D000312:Adrenal Hyperplasia, Congenital; D000308:Adrenocortical Hyperfunction / Q000097:blood; D000324:Adrenocorticotropic Hormone / Q000097:blood*; D000328:Adult; D001786:Blood Glucose; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007328:Insulin; D009075:MSH Release-Inhibiting Hormone; D008297:Male; D009074:Melanocyte-Stimulating Hormones / Q000097:blood*; D008797:Metyrapone
D001786:Blood Glucose; D007328:Insulin; D000324:Adrenocorticotropic Hormone; D009074:Melanocyte-Stimulating Hormones; D009075:MSH Release-Inhibiting Hormone; D008797:Metyrapone